JPWO2023204290A5 - - Google Patents
Info
- Publication number
- JPWO2023204290A5 JPWO2023204290A5 JP2024516323A JP2024516323A JPWO2023204290A5 JP WO2023204290 A5 JPWO2023204290 A5 JP WO2023204290A5 JP 2024516323 A JP2024516323 A JP 2024516323A JP 2024516323 A JP2024516323 A JP 2024516323A JP WO2023204290 A5 JPWO2023204290 A5 JP WO2023204290A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- nos
- chain variable
- cdr2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022069831 | 2022-04-21 | ||
| PCT/JP2023/015857 WO2023204290A1 (ja) | 2022-04-21 | 2023-04-21 | 多重特異性ナノ粒子 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023204290A1 JPWO2023204290A1 (https=) | 2023-10-26 |
| JPWO2023204290A5 true JPWO2023204290A5 (https=) | 2026-04-21 |
Family
ID=88419941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024516323A Pending JPWO2023204290A1 (https=) | 2022-04-21 | 2023-04-21 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2023204290A1 (https=) |
| WO (1) | WO2023204290A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025059385A2 (en) * | 2023-09-14 | 2025-03-20 | Outpace Bio, Inc. | Anti-mesothelin chimeric antigen receptors and methods of use |
| WO2025167631A1 (zh) * | 2024-02-05 | 2025-08-14 | 北京三诺佳邑生物技术有限责任公司 | 特异性结合HBV pre-S1抗原、PD-L1抗原和CD3抗原的多特异性抗体及其应用 |
| WO2025242098A1 (zh) * | 2024-05-21 | 2025-11-27 | 康诺亚生物医药科技（成都）有限公司 | 针对ceacam5的抗体偶联药物及其用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2695991A1 (en) * | 2007-08-09 | 2009-02-12 | Daiichi Sankyo Company, Limited | Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor |
| JP2016514676A (ja) * | 2013-03-15 | 2016-05-23 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | 四価二重特異性抗体 |
| AU2016267166A1 (en) * | 2015-05-26 | 2017-12-07 | The General Hospital Corporation | Liposomal nanoconstructs and methods of making and using the same |
| WO2017165464A1 (en) * | 2016-03-21 | 2017-09-28 | Elstar Therapeutics, Inc. | Multispecific and multifunctional molecules and uses thereof |
| CN109498817B (zh) * | 2017-09-14 | 2026-03-06 | 上海交通大学 | 一种多细胞靶向脂质体 |
| WO2020070041A1 (en) * | 2018-10-01 | 2020-04-09 | F. Hoffmann-La Roche Ag | Bispecific antigen binding molecules comprising anti-fap clone 212 |
| WO2020071554A1 (ja) * | 2018-10-05 | 2020-04-09 | 北海道公立大学法人 札幌医科大学 | がん幹細胞特異的抗体 |
| US11976133B2 (en) * | 2020-01-31 | 2024-05-07 | Gensun Biopharma Inc. | Bispecific T cell engagers |
| MX2022013797A (es) * | 2020-05-08 | 2022-11-30 | Genmab As | Anticuerpos biespecificos contra cd3 y cd20. |
-
2023
- 2023-04-21 WO PCT/JP2023/015857 patent/WO2023204290A1/ja not_active Ceased
- 2023-04-21 JP JP2024516323A patent/JPWO2023204290A1/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2023204290A5 (https=) | ||
| JP2019525771A5 (https=) | ||
| JP7812877B2 (ja) | キメラポリペプチド及びそれらの細胞膜における局在を変更する方法 | |
| KR20190065318A (ko) | 세포에 의해 발현되는 생물학적 활성을 조절하는 결합 분자 | |
| JP2025142045A5 (https=) | ||
| JP2020508334A5 (https=) | ||
| CA3075619A1 (en) | Methods and systems for performing a patient-specific immunotherapy procedure with chain-of-custody and chain-of-identity biological sample tracking | |
| JP2021532742A5 (https=) | ||
| JP2024532482A5 (https=) | ||
| JP2024511423A5 (https=) | ||
| JP2024524527A (ja) | がん治療において神経疼痛の消失または軽減をもたらす腫瘍関連抗原に結合する多重特異性抗体 | |
| CA3075630A1 (en) | Cd1d and tcr-nkt cells | |
| JP2023515055A5 (https=) | ||
| CN114853897B (zh) | 抗cd19/cd22/cd3三特异性抗体及用途 | |
| JP2024541476A5 (https=) | ||
| JP2023552724A5 (https=) | ||
| JP2023541132A (ja) | 免疫細胞におけるアダプターの誘導性発現のための系 | |
| WO2017028634A1 (zh) | 一种抗体融合蛋白及其制备方法与应用 | |
| CN119894930A (zh) | 一种双特异性抗体及其应用 | |
| JP2022552786A5 (https=) | ||
| JP2024513485A5 (https=) | ||
| CN115701999A (zh) | 用白介素-36工程化γδT细胞用于免疫疗法 | |
| US20240091263A1 (en) | Chimeric antigen receptors targeting albumin and their methods of uses | |
| WO2025081163A1 (en) | Compositions for the treatment of cancer | |
| HK40129592A (zh) | 抗-5t4抗体及用途 |